US FDA approves Novartis drug to treat kidney disease
The US Food and Drug Administration has approved the use of a Novartis drug to reduce excess protein in the urine of patients with a type of kidney disease. The drug Fabhalta is already approved to treat adults with paroxysmal nocturnal haemoglobinuria, a rare blood disorder.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO